Question: I am used to treating patients who report chronic heavy menstrual bleeding, but what can I do for a patient in my clinic who at this moment is actively losing excessive amounts of blood? She has to change her pad every 30-40 minutes and wear double protection to prevent spillage. I can tell she needs help now and may not be able to be referred.

Question: I’m a provider and am aware that there have been new developments in cervical cancer screening technologies. How do the updated guidelines take these developments into account, and how do they affect my practice? Dr. Michael Policar responds:  Since the publication of the chapter on Screening for Cervical, Ovarian, and Breast Cancer in Contraceptive Technology (22nd edition), there have been four new developments in cervical cancer screening, moving us closer to personalized management… As a clinician, you need to be aware of the updates in national guidelines, and in some cases, utilize these new technologies, depending on the logistics of cervical cancer screening in your practice. 

Clinicians and health educators may encounter patient concerns stemming from recent media coverage and legal actions regarding Depo-Provera and its potential link to meningiomas. This resource provides evidence-based responses to frequently asked questions, helping you guide informed, reassuring conversations. Use this guide, developed by Contraceptive Technology editor Alison Edelman, MD, MPH, to support patient-centered decision-making and address misconceptions with clarity and clinical confidence.